12:00 AM
 | 
Sep 07, 1999
 |  BC Week In Review  |  Clinical News  |  Clinical Results

UT-15: Phase II

UTHR researchers and colleagues presented data from a 26-patient study in which UT-15 was safe and gave a favorable...

Read the full 71 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >